Prof. Dr. Ozan Özkaya is a specialist in Pediatric Nephrology with experience in the diagnosis and management of a wide range of conditions related to this field. She provides care at Liv Hospital Bahçeşehir, focusing on precise medical treatment in line with the latest clinical practices to support patient health and improve quality of life.
Education
- 1992: Faculty of Medicine, Ondokuz Mayıs University Faculty of Medicine
- 1998: Pediatrics and Diseases, Gazi University Faculty of Medicine
- 2002: Pediatric Nephrology, Gazi University Faculty of Medicine
- 2011: Pediatric Rheumatology, Medical Specialization Board of the Ministry of Health
- 2011: New York University Langone Medical Center, Pediatric Rheumatology, visiting researcher
- 2015-2017: Education Coordinator, Okmeydanı Training and Research Hospital
- 2017: Istinye University Liv Hospital, Ulus Liv Hospital
Professional Experience
- 1993-1998: Gazi University, Pediatrics and Diseases, Research Assistant
- 1998-2002: Gazi University, Pediatric Nephrology, Research Assistant
- 2002-2004: Ondokuz Mayıs University Faculty of Medicine, Pediatric Nephrology, Assistant Professor
- 2004-2011: Ondokuz Mayıs University Faculty of Medicine, Pediatric Nephrology, Associate Professor
- 2011-2014: Ondokuz Mayıs University Faculty of Medicine, Professor
- 2011: New York University Langone Medical Center, Pediatric Rheumatology, visiting researcher
Certificates and Awards
- 2017: Long QT syndrome diagnosed in two sisters with propionic acidemia: a case report. J Pediatr Endocrinol Metab.
- 2017: Bilateral Idiopathic Carpal Tunnel Syndrome in a 4-Year-Old Girl. J Trop Pediatr.
- 2015: Success of eculizumab in the treatment of atypical hemolytic uremic syndrome. Pediatr Nephrol.
- 2014: Effect of creatine and pioglitazone on Hk-2 cell line cisplatin nephrotoxicity. Ren Fail.
- 2014: Effect of free creatine therapy on cisplatin-induced renal damage. Ren Fail.
- 2013: Urinary NGAL in septic preterm babies: A preliminary study. Am J Perinatol.
- 2013: Kidney Injury Molecule-1 as a promising biomarker for acute kidney injury in premature babies.
- 2013: An uncommon cause of acute kidney injury in young children: Cystinuria. J Pediatr Urol.
- 2012: Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients. Gene.
- 2012: Hyperkalaemia in a female patient with systemic lupus erythematosus: answers. Pediatr Nephrol.
